Junna Oba

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Respiratory Syndrome Coronavirus

Nitric Oxide Synthase

Top Venues

Risk management and healthcare policy

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Junna Oba, Masako Toriya, Yoshifumi Uwamino, Koichi Matsuo
Using a Systems Engineering Approach to Build a PCR Testing System at a Medical School During the COVID-19 Pandemic. Risk management and healthcare policy 17 (2024)
Junna Oba, Masako Toriya, Yoshifumi Uwamino, Koichi Matsuo
Using a Systems Engineering Approach to Build a PCR Testing System at a Medical School During the COVID-19 Pandemic. Risk management and healthcare policy 17 (2024)
Miles C Andrews, Junna Oba, Chang-Jiun Wu, Haifeng Zhu, Tatiana Karpinets, Caitlin A Creasy, Marie-Andrée Forget, Xiaoxing Yu, Xingzhi Song, Xizeng Mao, A Gordon Robertson, Gabriele Romano, Peng Li, Elizabeth M Burton, Yiling Lu, Robert Szczepaniak Sloane, Khalida M Wani, Kunal Rai, Alexander J F Lazar, Lauren E Haydu, Matias A Bustos, Jianjun Shen, Yueping Chen, Margaret B Morgan, Jennifer A Wargo, Lawrence N Kwong, Cara L Haymaker, Elizabeth A Grimm, Patrick Hwu, Dave S B Hoon, Jianhua Zhang, Jeffrey E Gershenwald, Michael A Davies, P Andrew Futreal, Chantale Bernatchez, Scott E Woodman
Multi-modal molecular programs regulate melanoma cell state. Nature communications 13 (1) (2022)
Junna Oba, Hiroaki Taniguchi, Masae Sato, Masaki Takanashi, Moe Yokemura, Yasunori Sato, Hiroshi Nishihara
SARS-CoV-2 RT-qPCR testing of pooled saliva samples: A case study of 824 asymptomatic individuals and a questionnaire survey in Japan. PloS one 17 (5) (2022)
Junna Oba, Scott E Woodman
The genetic and epigenetic basis of distinct melanoma types. The Journal of dermatology 48 (7) (2021)
Dai Ogata, Jason Roszik, Junna Oba, Sun-Hee Kim, Roland L Bassett, Lauren E Haydu, Keiji Tanese, Elizabeth A Grimm, Suhendan Ekmekcioglu
The Expression of CD74-Regulated Inflammatory Markers in Stage IV Melanoma: Risk of CNS Metastasis and Patient Survival. Cancers 12 (12) (2020)